SLS 14RS-521 ENGROSSED
Page 1 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
Regular Session, 2014
SENATE BILL NO. 556
BY SENATOR JOHNS
CONTROL DANGER SUBSTANCE. Amends frequency of reporting prescription
dispensing of certain substances to the state prescription monitoring board. (8/1/14)
AN ACT1
To amend and reenact R.S. 40:1006(B), relative to the reporting of prescription monitoring2
information; to provide for reporting at a frequency to be determined by the3
Louisiana Board of Pharmacy; and to provide for related matters.4
Be it enacted by the Legislature of Louisiana:5
Section 1. R.S. 40:1006(B) is hereby amended and reenacted to read as follows: 6
ยง1006. Reporting of prescription monitoring information7
* * *8
B. Each dispenser shall submit the required information in accordance with9
transmission methods and frequency established by the board. Each eligible10
prescription transaction shall be reported as soon as possible but in no event more11
than seven days no later than the next business day after the date of dispensing.12
* * *13 SB NO. 556
SLS 14RS-521 ENGROSSED
Page 2 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
The original instrument was prepared by Mary Dozier O'Brien. The
following digest, which does not constitute a part of the legislative
instrument, was prepared by Christopher D. Adams.
DIGEST
Johns (SB 556)
Present law provides that information on the prescribing of certain controlled dangerous
substances shall be reported no longer than seven days after the date of dispensing.
Proposed law amends present law to provide each eligible prescription shall be reported no
later than the next business day after the date of dispensing.
Effective August 1, 2014.
(Amends R.S. 40:1006(B))
Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Health and Welfare to
the original bill
1. Provides that each eligible prescription be reported no later than the next
business day after the date of dispensing.